RPH dividend yield – Ratchaphruek Hospital Public Announces 0.15 Cash Dividend.
March 20, 2023
Dividends Yield
On March 1 2023, Ratchaphruek Hospital Public ($SET:RPH) announced a 0.15 cash dividend per share. This comes after the hospital public paid out annual dividends per share of 0.45, 0.15, and 0.1 THB in the last three years, with dividend yields of 7.09%, 2.54%, and 1.75% respectively, averaging out at 3.79%. This dividend could be of great interest to investors who are looking to invest in dividend stocks as the ex-dividend date is set for March 13 2023. Ratchaphruek Hospital Public is offering a reasonable dividend yield and a good opportunity for investors who are interested in dividend stocks and looking to diversify their portfolios.
Price History
This news drove the stock price up by 0.8%, with the stock price opening at THB6.1 and closing at THB6.2 on the day. The previous closing price of 6.2 was an increase of 0.8% from the opening. The dividend payment is expected to be paid out in the near future, and is yet another sign of the company’s commitment to rewarding its shareholders with financial returns. This announcement is likely to have a positive effect on the stock price of RATCHAPHRUEK HOSPITAL PUBLIC in the coming days and weeks. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for RPH. More…
| Total Revenues | Net Income | Net Margin |
| 1.33k | 286.47 | 21.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for RPH. More…
| Operations | Investing | Financing |
| 483.66 | -82.29 | -322.29 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for RPH. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.01k | 285.82 | 3.16 |
Key Ratios Snapshot
Some of the financial key ratios for RPH are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 17.5% | 41.7% | 27.4% |
| FCF Margin | ROE | ROA |
| 30.3% | 13.2% | 11.3% |
Analysis
At GoodWhale, we have conducted an analysis on the wellbeing of RATCHAPHRUEK HOSPITAL PUBLIC. According to our results, RATCHAPHRUEK HOSPITAL PUBLIC is a low-risk investment in terms of both financial and business aspects. Upon further inspection, however, we have identified two risk warnings in the income sheet and balance sheet. We encourage you to register with us to gain access to our detailed findings, so you can make an informed decision when making investment decisions. More…
Peers
Ratchaphruek Hospital PCL is one of Thailand’s leading healthcare providers, competing with other giants such as Mahachai Hospital PCL, Thonburi Medical Center PCL, and InterMedical Care and Lab Hospital PCL. With a wide range of services including primary care, specialized care, diagnostics, and laboratory services, Ratchaphruek Hospital PCL is committed to delivering quality health care to its customers.
– Mahachai Hospital PCL ($SET:M-CHAI)
Mahachai Hospital PCL is a hospital and healthcare services provider based in Thailand. The company has a market capitalization of 5.6 billion as of 2023, indicating that it is a large publically traded healthcare provider. Mahachai Hospital PCL’s return on equity (ROE) of 20.13% has been a strong indication of the company’s financial health and performance. The ROE is a measure of a company’s profitability, which indicates that Mahachai Hospital PCL is a highly efficient enterprise that is able to generate returns on the shareholder’s investment. Additionally, the company’s high market capitalization indicates investor confidence in the company’s management and ability to sustain long-term growth.
– Thonburi Medical Center PCL ($SET:KDH)
Thonburi Medical Center PCL is a Thailand-based public company that provides healthcare services. The company offers services such as inpatient and outpatient care, as well as services in specialized areas such as neurology, pediatrics, and trauma care. As of 2023, its market capitalization stands at 1.84 billion USD, reflecting its strong financial performance over the years. Thonburi Medical Center PCL has achieved a return on equity of 10.61%, which indicates the company’s ability to generate profits by utilizing its equity assets efficiently. This impressive performance is a testament to the quality of services that the company provides.
– InterMedical Care and Lab Hospital PCL ($SET:IMH)
InterMedical Care and Lab Hospital PCL is a provider of medical and laboratory services in Thailand. The company has a market cap of 2.55 billion as of 2023 and has a Return on Equity (ROE) of 16.26%. InterMedical Care and Lab Hospital PCL has been able to exceed the average ROE of the industry and the market, indicating that the company has been able to generate more return with the same amount of equity relative to other companies in its industry. This strong ROE reflects the company’s strong competitive advantage and management performance. The impressive market capitalization of 2.55 billion is a testament to the success of the company’s operations in providing quality medical and laboratory services.
Summary
RATCHAPHRUEK HOSPITAL PUBLIC has been consistently paying dividends to its shareholders for the past three years. In the last three years, the dividend yields have been 7.09%, 2.54%, and 1.75%, respectively, with the average yield at 3.79%. This suggests that RATCHAPHRUEK HOSPITAL PUBLIC is a relatively attractive investment opportunity, with stable dividend payments and a relatively high return on investment. Investors looking for a reliable dividend income should consider investing in RATCHAPHRUEK HOSPITAL PUBLIC, as it is likely to continue to pay attractive dividends in the future.
